Gupta, I., Baranwal, P., Singh, G
Optum Rx Drug Pipeline Report New drugs and drug technologies are transforming the way we treat illnesses, but navigating their complexities and costs can be overwhelming
Targeting these pathways therapeutically aims to shift macrophages from a tumor-promoting M2-like state to a tumor-suppressing M1-like state ( Intrinsic tumor signaling pathways influencing macrophage polarization PTEN PTEN loss in HGSOC significantly impacts macrophage dynamics, shaping the tumor microenvironment
Antioxidant enzyme deficiencies, for dyslipidemic patients, were: 35% for sinus bradycardia and associated arrhythmias, 33% for sinus tachycardia, 33% for atrial fibrillation, 32% for atrial flutter and atrial extrasystolic arrhythmia, 30% for extrasystolic and ventricular arrhythmia, and 26% for paroxysmal supraventricular tachycardia